Successful Use of Tissue Plasminogen Activator in an Adolescent Male with Pyogenic Liver Abscess by Zee-Cheng, Janine et al.
Case Report
Successful Use of Tissue Plasminogen Activator in
an Adolescent Male with Pyogenic Liver Abscess
Janine Zee-Cheng ,1 Thomas Fox,2 Sonal Patel,3 and Samer Abu-Sultaneh4
1Division of Pediatric Hospital Medicine, Section of Pediatric Hospital Medicine, Department of Pediatrics,
Indiana University School of Medicine and Riley Hospital for Children at IU Health, Indianapolis, IN, USA
2Division of Pediatric Infectious Disease, Department of Pediatrics, Emory University School of Medicine, USA
3Division of Pediatric Gastroenterology, Department of Pediatrics, Emory University School of Medicine, USA
4Division of Pediatric Critical Care Medicine, Section of Pediatric Critical Care Medicine, Department of Pediatrics,
Indiana University School of Medicine and Riley Hospital for Children at IU Health, Indianapolis, IN, USA
Correspondence should be addressed to Janine Zee-Cheng; jzeechen@iu.edu
Received 24 November 2018; Accepted 1 April 2019; Published 14 April 2019
Academic Editor: Zsolt Molna´r
Copyright © 2019 Janine Zee-Cheng et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Large pyogenic liver abscess is a rare and difficult to treat entity in pediatric patients. Percutaneous drainage rather than open
surgical drainage has becomemore common in recent years, even for large abscesses. Percutaneous drainage can be complicated by
catheter obstruction.We present the case of a 16-year-old male presenting with abdominal pain, fever, and chills. He was diagnosed
with a 9-centimeter liver abscess. A CT-guided percutaneous drainage was placed. The catheter initially drained well, but then
became occluded. Tissue plasminogen activator was instilled into the catheter every 6 hours for a total of five doses, resulting in
increased drainage and improved clinical state of the patient. To our knowledge, this is the first reported use of tissue plasminogen
activator in pyogenic liver abscess in the pediatric population.
1. Introduction
Large pyogenic liver abscesses (PLA) are rare in pediatric
patients. Most diagnoses are made in adult patients about
50 years of age with an incidence of 8 to 20 cases per
100,000 admissions [1]. Symptoms of PLAs are nonspecific,
and physical examination findings may be subtle, which can
present a diagnostic challenge [2]. Despite the low incidence
in children of 0.007% to 0.04% of all hospital admissions,
PLAs have high mortality rates of 80-100% if left untreated
[3].
2. Case Presentation
A 16-year-old previously healthy male presented to the
emergency department with chills, abdominal pain, wors-
ening nausea, and shortness of breath. He was noted to
have increased work of breathing. Abdominal examination
revealed mild tenderness in the periumbilical area, but no
rebound guarding. His oral temperature was 38.6∘C, heart
rate 123 beats/min, blood pressure 121/69, and respiratory rate
20 breaths per minute. He was noted to have poor perfusion
with capillary refill of 4 seconds, which improved after fluid
resuscitation. Complete blood count showed a white blood
cell count at 18,300mm3, platelet count at 78,000/mm3,
and hemoglobin of 14.3 g/dL (14-17 g/dL). Blood chemistry
demonstrated high blood urea nitrogen at 27mg/dL, high
creatinine at 2.3mg/dL, high alanine aminotransferase at
442 IU/L, high aspartate aminotransferase at 343 IU/L, and
high total bilirubin at 2.8mg/dL. The patient received one
dose of ceftriaxone in the emergency department. He was
placed on vancomycin and piperacillin/tazobactam.
Thepatientwas admitted to pediatric intensive carewhere
he underwent abdominal ultrasound to investigate the acute
renal and liver injury. Ultrasound revealed a complex 9.3 x
9.2 cm heterogeneous-appearing mixed soft tissue and cystic
lesion within the dome of the right hepatic lobe (Figure 1(a)).
After discussion with surgical and infectious disease teams, a
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(a) Liver ultrasound performed prior to percutaneous
drain placement (9.26 cm in diameter on image; max-
imum dimension read as 9.3cm x 9.2cm in report)
(b) Liver ultrasound performed 3 days after percuta-
neous drain placement demonstrating increased size
of abscess
(c) Liver ultrasound performed after five doses of
tissue plasminogen activator administration (9.7 cm in
diameter on image; maximum dimension read as 11.3
× 6.2cm in report)
Figure 1
CT-guided 10 French pigtail percutaneous drainage catheter
(PD) was placed in the abscess and drained purulent brown
fluid.
The drained fluid grew Streptococcus anginosus, which
was penicillin susceptible, and antibiotic regimen was
changed from piperacillin/tazobactam and vancomycin to
ampicillin monotherapy. Metronidazole was added later in
his hospital course. Following drainage of the abscess, he
became hypotensive, necessitating norepinephrine infusion.
He developed respiratory failure requiring noninvasive pos-
itive pressure ventilation. Minimal fluid was drained from
PD in the first 3 days. Follow-up ultrasound two days after
the PD placement demonstrated abscess enlargement (18.4
× 117 cm) (Figure 1(b)). After multispecialty discussion, open
surgical drainage was deferred. Instead, tissue plasminogen
activator (tPA) was instilled into the PD. Four milligrams tPA
was diluted in 50mL saline, capped for one hour, and then
drained to gravity. This was performed every 6 hours for total
of five doses. Following instillation of tPA, catheter drainage
significantly increased, and the patient’s respiratory status
and fever curve improved significantly (Figure 2). Follow-
up ultrasound after 5 doses of tPA therapy demonstrated
a decrease in abscess size to 11.3 × 6.2cm (Figure 1(c)).
The patient was discharged home on amoxicillin/clavulanate
and metronidazole, with the drain in place, after 14 days
of hospitalization. Ultrasound performed eleven days after
hospital discharge demonstrated further decrease in size of
abscess to 7× 4.9 cm.ThePDwas removed 34 days after initial
placement.
3. Discussion
Pyogenic liver abscesses (PLA) are difficult to diagnose; the
triad of fever, jaundice, and right upper quadrant discomfort
is present in only 10 percent of patients [4], while fever
and right upper quadrant pain without jaundice occurs in
just 30% of patients [2]. In developed countries, PLAs occur
most frequently in immunocompromised hosts and occur in
conjunction with infections in the abdominal cavity, which
can aid in diagnosis [5, 6]. In developing countries, PLAs
are more common, reported in more than 79 in 100,000
in India [7]. Waghmare et al. studied 34 patients with PLA
less than 12 years of age in India, only four of which had
predisposing factors for PLA. Three of the patients were
managed with intravenous antibiotics only; nine underwent
percutaneous needle aspiration with ultrasound guidance; 20
patients required PD. None of the patients required open
surgical drainage [8].
Although PLAs are associated with predisposing fac-
tors, both pediatric and adult cases have been reported
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Figure 2: Daily percutaneous drainage (PD) output and maximum
temperature (Tmax) during tissue plasminogen activator (tPA)
treatment. Solid arrow indicates PD catheter placement and dashed
arrows indicate tPA administration days (total of five doses over two
days).
in immunocompetent patients [9–11]. Prompt imaging is
important for early diagnosis of liver abscess, if the patient has
suggestive symptoms or abnormal laboratory liver function
tests, high C-reactive protein, or leukocytosis [12]. Failure to
treat PLA is uniformly fatal [13].
Liver abscesses larger than 5 cm in size generally require
prompt drainage for resolution of symptoms. It was previ-
ously considered a high morbidity disease requiring open
surgical drainage, with mortality rates between 9 and 80%
[13]. In recent years, there has been a shift from open surgical
drainage to PD [14, 15]. Both these treatment options have
been demonstrated to effectively drain PLA [16, 17]. Surgical
drainage may be preferred in cases in which there is no
clinical response after 4-7 days of drainage via catheter;
multiple, large, or loculated abscesses; thick-walled abscess
with viscous pus; or concurrent intra-abdominal surgical
pathology. However, PD is a less invasive, lower-risk proce-
dure and is now amainstay of treatment [13]. Large abscesses,
especially if loculated or containing thick viscid fluid, may
fail by PD due to catheter occlusion [18]. Tissue plasminogen
activator can be used to improve PD results and avoid open
surgical drainage.
Although this patient is physiologically close to adult, he
fell outside of the usual age range for PLA in adults and was
being treated by pediatric specialists in a pediatric hospital.
The highmorbidity andmortality rates in untreated pediatric
patients necessitate effective treatment. Tissue plasminogen
activator has been successfully used to break viscous pus
and facilitate drainage of complex parapneumonic empyema
in pediatric population [19]. It has been used to facilitate
drainage of abdominal abscess in neonatal, pediatric, and
adult patients [20, 21]. Criteria for using tPA in parapneu-
monic effusion include viscous contents with little or no
drainage at immediately postdrainage imaging ormacroscop-
ically purulent fluid at initial drainage [22]. Adjunctive tPA
in the abdominal pelvic abscess cavities has been shown to
be safe in adults, even in patients who are being systemically
anticoagulated [23]. There currently exist no standardized
protocols for treatment with tPA [23], and no prior studies
have documented use of tPA in pediatric PLA.
To our knowledge, this is the first reported case of suc-
cessful usage of tPA to facilitate PD of pediatric liver abscess.
The tPA was effective in facilitating the drainage of the PLA
in our case that resulted in both clinical and radiological
improvements. Caution may be needed when tPA is used as
tPA is associated with bleeding; however, it has been safely
used in adult patients with intra-abdominal abscess, even in
the setting of systemic anticoagulation [23].
4. Conclusions
Percutaneous drainage is a safe, effective, less invasive treat-
ment for large pediatric liver abscesses. Tissue plasmino-
gen activator administration can improve drainage in large
abscesses, preventing the need for open surgical drainage.
More studies are needed to evaluate this treatment option.
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